Caseware UK (AP4) 2016.0.181 2016.0.181 2018-05-312018-05-31The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.falsetrueNo description of principal activityfalse2017-05-23 10785555 2017-05-22 10785555 2017-05-23 2018-05-31 10785555 2018-05-31 10785555 c:Director1 2017-05-23 2018-05-31 10785555 c:Director1 2018-05-31 10785555 c:RegisteredOffice 2017-05-23 2018-05-31 10785555 d:CurrentFinancialInstruments 2018-05-31 10785555 d:CurrentFinancialInstruments d:WithinOneYear 2018-05-31 10785555 d:ShareCapital 2018-05-31 10785555 d:RetainedEarningsAccumulatedLosses 2017-05-23 2018-05-31 10785555 d:RetainedEarningsAccumulatedLosses 2018-05-31 10785555 c:FRS102 2017-05-23 2018-05-31 10785555 c:AuditExemptWithAccountantsReport 2017-05-23 2018-05-31 10785555 c:FullAccounts 2017-05-23 2018-05-31 10785555 c:PrivateLimitedCompanyLtd 2017-05-23 2018-05-31 iso4217:GBP

Registered number: 10785555










JP MEDICAL CONSULTANCY LIMITED








UNAUDITED

DIRECTOR'S REPORT AND FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 31 MAY 2018

 
JP MEDICAL CONSULTANCY LIMITED
 

COMPANY INFORMATION


Director
J R Pelta (appointed 23 May 2017)




Registered number
10785555



Registered office
Kingsridge House
601

London Road

Westcliff-on-sea

Essex

SS0 9PE




Accountants
MWS
Chartered Accountants

Kingsridge House

601 London Road

Westcliff-On-Sea

Essex

SS0 9PE





 
JP MEDICAL CONSULTANCY LIMITED
 

CONTENTS



Page
Director's report
 
 
1
Accountants' report
 
 
2
Statement of income and retained earnings
 
 
3
Balance sheet
 
 
4
Notes to the financial statements
 
 
5 - 7


 
JP MEDICAL CONSULTANCY LIMITED
 

 
DIRECTOR'S REPORT
FOR THE PERIOD ENDED 31ST MAY 2018

The director presents her report and the financial statements for the period ended 31 May 2018.

Director

The director who served during the period was:

J R Pelta (appointed 23 May 2017)

Small companies note

In preparing this report, the director has taken advantage of the small companies exemptions provided by section 415A of the Companies Act 2006.

This report was approved by the board and signed on its behalf.
 





J R Pelta
Director

Date: 22 October 2018

Page 1

 
JP MEDICAL CONSULTANCY LIMITED
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF JP MEDICAL CONSULTANCY LIMITED
FOR THE PERIOD ENDED 31ST MAY 2018

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of JP Medical Consultancy Limited for the period ended 31st May 2018 which comprise the Statement of income and retained earnings, the Balance sheet and the related notes from the Company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW)we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/en/ members/regulations-standards-and-guidance/.

This report is made solely to the director of JP Medical Consultancy Limited in accordance with the terms of our engagement letter dated 22/06/2017Our work has been undertaken solely to prepare for your approval the financial statements of JP Medical Consultancy Limited and state those matters that we have agreed to state to the director of JP Medical Consultancy Limited in this report in accordance with ICAEW Technical Release TECH07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than JP Medical Consultancy Limited and its director for our work or for this report. 

It is your duty to ensure that JP Medical Consultancy Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit or loss of JP Medical Consultancy Limited. You consider that JP Medical Consultancy Limited is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or review of the financial statements of JP Medical Consultancy Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  



MWS
 
Chartered Accountants
  
Kingsridge House
601 London Road
Westcliff-On-Sea
Essex
SS0 9PE
22 October 2018
Page 2

 
JP MEDICAL CONSULTANCY LIMITED
 

STATEMENT OF INCOME AND RETAINED EARNINGS
FOR THE PERIOD ENDED 31 MAY 2018

2018
Note
£

  

Turnover
  
186,183

Gross profit
  
186,183

Administrative expenses
  
(49,553)

Operating profit
  
136,630

Interest receivable and similar income
  
31

Profit before tax
  
136,661

Tax on profit
  
(26,240)

Profit after tax
  
110,421

  

  

Profit/(loss) for the period
  
110,421

Dividends declared and paid
  
(26,000)

Retained earnings at the end of the period
  
84,421
The notes on pages 5 to 7 form part of these financial statements.

Page 3

 
JP MEDICAL CONSULTANCY LIMITED
REGISTERED NUMBER: 10785555

BALANCE SHEET
AS AT 31 MAY 2018

2018
Note
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
2,605

Cash at bank and in hand
 5 
114,076

  
116,681

Creditors: amounts falling due within one year
 6 
(32,160)

Net current assets
  
 
 
84,521

Total assets less current liabilities
  
84,521

  

Net assets
  
84,521


Capital and reserves
  

Called up share capital 
  
100

Profit and loss account
  
84,421

  
84,521


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of Companies Act 2006.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




J R Pelta
Director

Date: 22 October 2018

The notes on pages 5 to 7 form part of these financial statements.

Page 4

 
JP MEDICAL CONSULTANCY LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31ST MAY 2018

1.


General information

JP Medical Consultancy Limited is a private company limited by shares and incorporated in England. Its registered office is Kingsridge House, 601 London Road, Westcliff-On-Sea, Essex, SS0 9PE
Its principal place of business is Studio 4, London, SE1 2NZ

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in the Statement of income and retained earnings using the effective interest method.

 
2.4

Taxation

Tax is recognised in the Statement of income and retained earnings, except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

 
2.5

Debtors

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 5

 
JP MEDICAL CONSULTANCY LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31ST MAY 2018

2.Accounting policies (continued)

 
2.6

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.7

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.8

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in the case of an out-right short-term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost.

 
2.9

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the period was 0.


4.


Debtors

2018
£


Trade debtors
2,160

Other debtors
205

Prepayments and accrued income
240

2,605


Page 6

 
JP MEDICAL CONSULTANCY LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31ST MAY 2018

5.


Cash and cash equivalents

2018
£

Cash at bank and in hand
114,076

114,076



6.


Creditors: Amounts falling due within one year

2018
£

Corporation tax
26,240

Other taxation and social security
5,070

Accruals and deferred income
850

32,160



Page 7